Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
The Outlook for Alemtuzumab in Multiple Sclerosis.
Assessing dalfampridine efficacy in the physician's office.
Early respiratory evaluation should be carried out systematically in patients with multiple sclerosis.
Gene flow from North Africa contributes to differential human genetic diversity in southern Europe.
Erratum to: The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Early and Extensive Spinal White Matter Involvement in Neuromyelitis Optica.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Pharmaceutical approval update.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Multiple sclerosis in children.
What are exosomes and how can they be used in multiple sclerosis therapy?
Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Exercising away the blues: can it help multiple sclerosis-related depression?
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
584
585
586
587
588
589
590
591
592
…
next ›
last »